Evidence map›Paper›PMID 26392001›Full record

ArticleLasers in surgery and medicine2016

Confocal imaging of carbon dioxide laser-ablated basal cell carcinomas: An ex-vivo study on the uptake of contrast agent and ablation parameters.

Heidy Sierra, Shadi Damanpour, Brian Hibler, Kishwer Nehal, Anthony Rossi, Milind Rajadhyaksha

Abstract read
In one paragraph

Article in Lasers in surgery and medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. [Laser treatment of basal cell carcinoma].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2018
    Review
  5. Article
  6. Article
  7. Novel approaches to imaging basal cell carcinoma.Future oncology (London, England) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Heidy SierraDermatology Service, Memorial Sloan Kettering Cancer Center, 16 E. 60th Street, 4th Floor, New York, 10022, New York.
Shadi DamanpourUniversity of Miami Miller School of Medicine, Miami, 33136, Florida.
Brian HiblerDermatology Service, Memorial Sloan Kettering Cancer Center, 16 E. 60th Street, 4th Floor, New York, 10022, New York.
Kishwer NehalDermatology Service, Memorial Sloan Kettering Cancer Center, 16 E. 60th Street, 4th Floor, New York, 10022, New York.
Anthony RossiDermatology Service, Memorial Sloan Kettering Cancer Center, 16 E. 60th Street, 4th Floor, New York, 10022, New York.
Milind RajadhyakshaDermatology Service, Memorial Sloan Kettering Cancer Center, 16 E. 60th Street, 4th Floor, New York, 10022, New York.
Memorial Sloan Kettering Cancer Center · USUniversity of Miami · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Intra-operative confocal imaging to guide Mohs surgeryR01EB012466 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI RAJADHYAKSHA, MILIND · 2010 to 2012
$2.3M
Peri-operative confocal imaging-guided laser ablation of basal cell carcinomasR01EB020029 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI RAJADHYAKSHA, MILIND · 2015 to 2018
$2.2M
NCI NIH HHS P30 CA008748NIBIB NIH HHS R01 EB012466NIBIB NIH HHS R01EB012466NIBIB NIH HHS R01 EB020029
6 · The paper itself

Abstract

BACKGROUND AND

objectivesLaser ablation can be an effective treatment for the minimally invasive removal of superficial and early nodular basal cell carcinomas (BCCs). However, the lack of histological confirmation after ablation results in high variability of recurrence rates and has been a limitation. Reflectance confocal microscopy (RCM) imaging, combined with a contrast agent, may detect the presence (or absence) of residual BCC tumors directly on the patient and thus provide noninvasive histology-like feedback to guide ablation. The goal of this ex vivo bench-top study was to determine affective ablation parameters (fluence, number of passes) for a CO2 laser that will allow both removal of BCCs and control of the underlying thermal coagulation zone in post-ablated tissue to enable uptake of contrast agent and RCM imaging. MATERIALS AND

methodsWe used 72 discarded fresh normal skin specimens and frozen BCC tumor specimens to characterize the depth of ablation and to evaluate uptake of contrast agent and image quality. Acetic acid was used to enhance nuclear brightness ("acetowhitening") during imaging pre- and post-ablation. Histology sections of the post-ablated imaged surface were visually examined for the appearance of nuclear and dermal morphology and compared to the RCM images.

resultsResults for 1-3 passes of 5.5 J/cm(2), 6.5 and 7.5 J/cm(2), and 1-2 passes of 8.5 J/cm(2) showed the uptake of acetic acid for contrast and RCM imaging of the presence and absence of residual BCC tumors in post-ablated tissue. Morphologic details in the images were validated by the histology.

conclusionThe use of effective ablation parameters may enable RCM imaging to guide ablation.

Indexed as

Basal Cell CarcinomaContrast MediaHumansLasers, GasMicroscopy, ConfocalSkin NeoplasmsTreatment OutcomeContrast Mediaimage-guided laser ablationless invasive skin cancer treatmentnonmelanoma skinc cancerreflectance confocal microscopy

Identifiers

PMID26392001
PMCPMC4769922
OpenAlexW1712000487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.